LONDON, September 28, 2015 /PRNewswire/ --
Elsevier is contributing £100,000 to Cancer Research UK's 'Create the Change' fundraising campaign in support of establishing the UK's new Francis Crick biomedical research institute.
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced a major donation of £100,000 towards Cancer Research UK's fundraising campaign to help build the Francis Crick Institute, a pioneering medical research facility in the heart of London.
The new state-of-the-art biomedical research institute, currently being built in King's Cross and due to open in 2016, will see more than 1,200 scientists collaborating to discover the biology underlying major human diseases - cancer, heart disease, lung disease, infectious diseases such as HIV and malaria and many more.
Elsevier's donation to Cancer Research UK (CRUK), one of the Crick's six founder partners, will help establish this significant and distinctive new biomedical research institute, which aims to make the next leap forward in biomedical research by "translating the latest laboratory discoveries into the next generation of medical breakthroughs," a mission strongly shared by Elsevier.
Harpal Kumar, Chief Executive Officer at Cancer Research UK, said "This donation from Elsevier, a world-leading research information company, marks a significant step in our effort to bring together a multitude of stakeholders united by a common goal to tackle the hardest problems in biomedical research today."
Ron Mobed, Chief Executive Officer at Elsevier, said "Elsevier is interested not just in the publication of research findings, but in the utility of those findings in the practical implementation of new research and in policy decision making. The Crick's commitment to excellence, emphasis on multidisciplinary research, focus on young and emerging talent and new ways of collaborating are very much aligned with our mission. It represents the future of how science could be applied to benefit society and is an endeavor we very much want to support."
The Francis Crick Institute is a collaboration between six of the world's leading medical research organisations: Cancer Research UK, The Medical Research Council, The Wellcome Trust, UCL (University College London), King's College London and Imperial College London. With a unique multidisciplinary approach to unravelling the mysteries behind major diseases and dedicated to research excellence, the institute will have the scale, vision and expertise to tackle challenging scientific questions underpinning health and disease.
More information about the Francis Crick Institute can be found at CRUK.ORG/CRICK.
About The Francis Crick Institute
The Francis Crick Institute is a world-leading centre of biomedical research and innovation. It will house 1,200 leading scientists from a variety of disciplines working together under one roof to tackle the biggest health challenges faced by humankind. Dedicated to research excellence, the institute will have the scale, vision and expertise to tackle challenging scientific questions underpinning health and disease. Due for completion in 2016, The Francis Crick Institute is a visionary collaboration between six of the world's leading medical research organisations: Cancer Research UK, the Medical Research Council, the Wellcome Trust, UCL (University College London), King's College London and Imperial College London. It will be world-class with a strong national role - training scientists and developing ideas for public good. http://www.crick.ac.uk
About Cancer Research UK
Cancer Research UK is the world's leading cancer charity dedicated to saving lives through research.
Cancer Research UK's pioneering work into the prevention, diagnosis and treatment of cancer has helped save millions of lives. Cancer Research UK receives no government funding for its life-saving research. Every step it makes towards beating cancer relies on every pound donated. Cancer Research UK has been at the heart of the progress that has already seen survival rates in the UK double in the last forty years. Today, 2 in 4 people survive cancer. Cancer Research UK's ambition is to accelerate progress so that 3 in 4 people will survive cancer within the next 20 years. Cancer Research UK supports research into all aspects of cancer through the work of over 4,000 scientists, doctors and nurses. Together with its partners and supporters, Cancer Research UK's vision is to bring forward the day when all cancers are cured. For further information about Cancer Research UK's work or to find out how to support the charity, please call + 44 300 123 1022 or visit http://www.cancerresearchuk.org. Follow us on Twitter and Facebook.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions - among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey - and publishes over 2,500 journals, including The Lancet and Cell, and more than 33,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group plc, a world-leading provider of information solutions for professional customers across industries. http://www.elsevier.com
For further information about Cancer Research UK, please contact Jenna Coles on +44-203-469-8076 / email@example.com
VP Corporate Relations, Elsevier